Business Case - Microsoft



-Business Case

[This front sheet should reflect the branding requirements of the Trust. The below is only a guide and your local Trust Business Case template may require additional information. Costs are for guidance only and vary between Trusts/regions. Green text is for your guidance and should be removed before business case sent for submission or review]

|Project Name: |IV Iron Anaemia Clinic |

|Date: | |Release: |Draft/Final |

|Author: | |

|Owner: | |

|Client: | |

|Document Number: | |

[Major headings are included in contents list – edit as required]

|Contents |Executive Summary |

| |Introduction |

| |Drivers for change that support the need for a coordinated approach to anaemia |

| |management: |

| |Reason, aims and purpose |

| |Expected Benefits & Outcomes |

| |Outcome measures: |

| |Expected Dis-benefits |

| |Timescale |

| |Financial Appraisal |

| |Clinical / Non-Financial Benefits Assessment |

| |Environmental Impact Assessment |

| |Risk Assessment and Management |

| |Service Description/Care Pathway |

| |Evidence Base for an IV iron anaemia clinic |

| |Conclusion and approvals |

| |Appendices |

| |Appendix 1: Intravenous iron preparations licensed in the UK |

| |Appendix 2: Patient Information |

| |Appendix 3: HRG code/tariff |

| |References |

| |Acknowledgements |

Executive Summary

[Highlight the key points in the Business Case, which should include important benefits and the return on investment. These could be from the template below but should be made specific to the Trusts decision and aims you hope to achieve]

Introduction

Pre-operative iron deficiency anaemia (IDA) is common and associated with poor post-operative outcomes. It is good clinical practice to diagnose and appropriately treat preoperative anaemia. This is likely to reduce the risk of such patients requiring intra/post-operative blood transfusion which exposes patients to additional risks including increased morbidity. This strategy is likely to improve clinical outcomes for patients undergoing planned major surgery and reduce the associated cancellation rate. A standardised approach for the detection, evaluation and management of anaemia in the pre-operative setting has been internationally identified as an unmet medical need.

A 2012 data briefing by The Kings Fund (Tian et al 2012) indicated IDA as an ambulatory care-sensitive condition (ACSC – a condition for which effective management and treatment should prevent admission to hospital). It went on to say that, high levels of admissions for ACSAs often indicate poor co-ordination between the different elements of the health care system and that an emergency admission for an ACSC is a sign of the poor overall quality of care.

(See Evidence Base for an IV iron anaemia clinic)

Drivers for change that support the need for a coordinated approach to anaemia management:

• [Add in information from local audit or results from National Comparative Audit surgical PBM, that show the size of the problem within Trust – expand this point as required to make issue a local concern that needs an anaemia clinic to improve situation]

• NHS Outcomes Framework 2013/14, Domain 2, Improvement area 2.3: Enhancing quality of life for people with long-term conditions. Reducing time spent in hospital by people with long-term conditions – unplanned hospitalisations for chronic ambulatory care sensitive patients. (CCG Quality Premium attached to this service) [Add in other NHS Outcomes Framework domains and indications that fit your Trust]

• National Blood Transfusion Committee Patient Blood Management Recommendations 2014 () advise the following:

o Provide arrangements for the timely identification and correction of anaemia before elective surgery which is likely to involve significant blood loss using WHO definitions of anaemia i.e. Hb in adult males ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download